Filters

Anti-BCL9 (Polyclonal), ALEXA Fluor 594

Anti-BCL9 (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Supplier BIOSS POLYCLONAL ANTIBODIES
Price 489
Size 100 microliters
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismRabbit (Oryctolagus cuniculus)
Target Protein/PeptideBCL9
SpecificityThis antibody reacts specifically with BCL9
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsN/A
Antigen SourceKLH conjugated synthetic peptide derived from human BCL9
Gene ID101060700
Swiss ProtN/A
ApplicationsIF(IHC-P)
Applications with corresponding dilutionsIF(IHC-P)(1:50-200)
Cross reactive species Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information Bcl-9L exists as multiple alternatively spliced isoforms and is thought to be involved in tumorigenesis, Bcl-9L functions as a transcriptional activator that forms a complex with Parafibromin and Î, Expressed in breast tissue, Jacobsen syndrome, Jervell and Lange-Nielsen syndrome, Niemann-Pick disease, The gene encoding Bcl-9L maps to human chromosome 11, as well as in eye, hereditary angioedema and Smith-Lemli-Opitz syndrome are associated with defects in genes that maps to chromosome 11, lung, possibly playing a role in tumor transformation and metastasis, prostate and various carcinomas, which houses over 1, ², ², -catenin, -catenin and is thought promote the transcriptional activity of Parafibromin and enhance the neoplastic transforming activity of Î, 400 genes and comprises nearly 4% of the human genome, 499 amino acid protein that localizes to the nucleus and contains a specialized C-terminal domain that is important for its overall activity, Bcl-9L is a 1
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Also known asBCL9 Polyclonal Antibody
Other nameAnti-BCL9 Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetBCL9
Short nameAnti-BCL9 (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-B-cell CLL/lymphoma 9 (polyclonal)
Alternative techniquepolyclonals
Alternative to gene target BCL9 and IDBG-101829 and ENSG00000116128 and 607, BCL9 and IDBG-633778 and ENSBTAG00000002422 and 788729, Bcl9 and IDBG-176803 and ENSMUSG00000038256 and 77578, LGS, beta-catenin binding, nuclei, this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005801 and cis- this GO lgi network and cellular component this GO :0008013 and beta-catenin binding and molecular function this GO :0014908 and myotube differentiation involved in skeletal muscle regeneration and biological process this GO :0035019 and somatic stem cell maintenance and biological process this GO :0035914 and skeletal muscle cell differentiation and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0060070 and canonical Wnt signaling pathway and biological process, this GO :0005515: protein binding, this GO :0005515: protein binding and also this GO :0008013: beta-catenin binding, this GO :0008013: beta-catenin binding, B-cell CLL/lymphoma 9
Identity 1008
Gene BCL9
Long gene name B-cell CLL/lymphoma 9
Locus 1q21, 2
Discovery year 1997-07-01
GenBank acession Y13620
Entrez gene record 607
Pubmed identfication 9490669
RefSeq identity NM_004326
Havana BLAST/BLAT OTTHUMG00000014031

Similar products

Subscribe to our Newsletter